A multi-national, randomized phase II/III study with Caelyx vs Caelyx/carboplatin vs weekly paclitaxel/carboplatin in patients with platinum-resistant epithelial ovarian cancer after first or second-line chemotherapy

Trial Profile

A multi-national, randomized phase II/III study with Caelyx vs Caelyx/carboplatin vs weekly paclitaxel/carboplatin in patients with platinum-resistant epithelial ovarian cancer after first or second-line chemotherapy

Not yet recruiting
Phase of Trial: Phase II/III

Latest Information Update: 08 Jun 2015

At a glance

  • Drugs Doxorubicin liposomal (Primary) ; Carboplatin; Paclitaxel
  • Indications Ovarian cancer
  • Focus Therapeutic Use
  • Acronyms PROVE
  • Most Recent Events

    • 20 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top